Dr. Ümit Aktaş ile İlaçsız Yaşam
@umitaktascom • Joined October 2, 2011
At a glance
Subscribers
Last 19 days1.54M
Views
Last 19 days161M
Videos
Last 19 days897
Charts
Subscribers, views & videos over time
Subscribers gained (weekly) · 6 mo
Views gained (weekly) · 6 mo
Subs milestone changes (up to 30)
Views milestone changes (up to 30)
Engagement
Avg. views per video
179K
Total views ÷ total videos
Views per subscriber
104×
Total views ÷ subscribers
Subs per video
1.72K
Subscribers ÷ total videos
Revenue estimate
Details →Total (all-time): $112K – $322K
Daily avg.: $193 – $553
Weekly avg.: $1.35K – $3.86K
Last 19 days: $3.67K – $10.4K
Based on estimated $0.7–$2 CPM.
Analytics tables
Analytics Table:Dr. Ümit Aktaş ile İlaçsız Yaşam
| Date | subscribers | views | videos |
|---|---|---|---|
Jul 6, 2026 Jul 6 Mon | 1.54M -- | 161M +550K | 897 +4 |
Jun 29, 2026 Jun 29 Mon | 1.54M -- | 160M +1.52M | 893 +8 |
Jun 22, 2026 Jun 22 Mon | 1.54M -- | 159M +2.46M | 885 +8 |
Jun 19, 2026 Jun 19 Fri | 1.54M +10.0K | 156M +7.41M | 877 +27 |
May 28, 2026 May 28 Thu | 1.53M -- | 149M -- | 850 -- |
Subscribers gained (weekly)
| Week | Subscribers gained | Change vs prev |
|---|---|---|
Jun 19, 2026 | 10.0K | +10.0K |
Jun 22, 2026 | 0 | -10.0K |
Jun 29, 2026 | 0 | -- |
Jul 6, 2026 | 0 | -- |
Views gained (weekly)
| Week | Views gained | Change vs prev |
|---|---|---|
Jun 19, 2026 | 7.41M | +7.41M |
Jun 22, 2026 | 2.46M | -4.95M |
Jun 29, 2026 | 1.52M | -942K |
Jul 6, 2026 | 550K | -970K |
About
Merhaba, ben Dr. Ümit Aktaş. Sağlıklı yaşamı mümkün kılmanın yolu, koruyucu hekimlikten geçer. Hastalıkları önlemek tedavi etmekten daha kolaydır. Doğal beslenerek, gerektiğinde fitoterapiden yararlanarak ilaçsız yaşamak ve hastalandıktan sonra da şifa bulmak mümkün. “Önce zarar verme” ilkesini benimsemiş bir hekim ol…
- Handle
- @umitaktascom
- Joined
- October 2, 2011
More features coming
We're working on new analytics and tools. Stay tuned.
Growth Rankings
Türkiye · Education
Subs gained
#2,506
Views gained
#3,814
Categories
More features coming
We're working on new analytics and tools. Stay tuned.